Sanofi Consumer Healthcare India Share Price

Sanofi Consumer Healthcare India Limited was incorporated on May 10, 2023, as part of Sanofis global strategy to establish a standalone Consumer Healthcare business. This strategic move resulted in the demerger of the Consumer Healthcare business from Sanofi India Limited (SIL) into the Company through a Scheme of Arrangement, thereby creating a distinct legal entity. The Scheme of Arrangement, which was sanctioned by the National Company Law Tribunal, Mumbai (NCLT) enabled the seamless transfer and vesting of all assets, liabilities, and operations of SIL to the Company.Pursuant to the Scheme, the Consumer Healthcare Division (CHC) business of Sanofi India Limited (SIL) got demerged into the Company as a going concern through the Scheme of Arrangement and became effective from June 1, 2024. In terms of said Scheme, the Company allotted 23,030,622 Equity Shares to the eligible shareholders of Sanofi India Limited (SIL) upon the demerger process. The demerger was strategically undertaken to facilitate independent and focused management for both businesses, enhance operational efficiency, provide greater transparency for stakeholders, and unlock shareholder value. The effective date of the Scheme was June 1, 2023. As per the Scheme, eligible shareholders of SIL received one fully paidup equity share of the Company for every share they held in SIL on June 13, 2024.The Clayton, Dubilier Rice group (CDR Group) acquired majority control over Opal Bidco SAS and, has exercised ultimate indirect control over the Company in FY25.

As of Mar '26, Sanofi Consumer Healthcare India’s market capitalisation stood at ₹10,517.39 crores. Shareholding as of Mar '26 shows promoters holding 71.3%, with FIIs at 2.8%, DIIs at 17.5%, and public at 8.4%.